spacer
home > ebr > winter 2002 > realising the potential of human cells for therapy
PUBLICATIONS
European Biopharmaceutical Review

Realising the Potential of Human Cells for Therapy

Cell therapy offers the potential to revolutionise health care. Instead of taking medicines that address only the symptoms of chronic disease, cell implants and engineered tissues will be able to cure a broad range of health conditions. The potential returns, both in terms of clinical benefit and financial reward, are significant. Not only can cell therapies displace expensive medicines, they can also greatly reduce the costs of supporting patients on long-term medical regimes. This is not a theoretical proposition - cell and cell-derived therapies are already being used effectively for a variety of applications.


Read full article from PDF >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Dr Will West, Product Development Director at CellFactors Dr Will West is Product Development Director at CellFactors plc, where his main focus has been on developing and commercialising SkeletexTM, a human cell-derived matrix that induces bone formation.
His scientific background is in immunology, virology and cell culture, and he completed his PhD, sponsored by Unilever (UniPath), in 1992. Following this, Dr West held a post-doctoral position at the National Institute of Biological Standards and Control, working on HIV vaccines and MHC proteins. Dr West subsequently worked at Procter & Gamble, responsible for product and claims development in a number of health care therapeutic areas. He has an MBA from London Business School.

spacer
Dr Will West
spacer
spacer
Print this page
Send to a friend
Privacy statement
News and Press Releases

MedPharm announce expansion of partnership with Palvella Therapeutics in developing a new treatment for the debilitating rare disease, pachyonychia congenita

MedPharm Ltd have announced the expansion of their partnership with Palvella Therapeutics, Inc., a Philadelphia-based biopharmaceutical company focused on developing and commercialising therapies for debilitating, rare genetic diseases. To date, MedPharm has employed its world-renowned specialist formulation expertise to support Palvella’s development of a novel, high-strength rapamycin topical formulation for application to the skin (PTX 022) as a disease-modifying treatment for pachyonychia congenita (PC). Most recently, MedPharm has made arrangements to manufacture the clinical (IMP) batches for use in Palvella’s upcoming Phase 2/3 clinical study.
More info >>

White Papers

Mauritius Island – An Emerging Centre for R&D in Biotechnology and the Life Sciences

CIDP (Centre International de Développement Pharmaceutique)

Mauritius, the tropical island situated in the Indian Ocean and known worldwide for its beautiful beaches, is also internationally recognised for its rule of law, and political and social stability. Over the past few years, the economy has been successfully transitioned from a monocrop to a diversified innovation-driven and knowledge-based economy, resting on agribusiness, export-oriented manufacturing, tourism, financial services, property development and real estate, ICT-BPO, the seafood industry, a free port, logistics and a nascent ocean economy. Emerging sectors such as healthcare and life sciences are presenting some niche areas for the taking, and the enabling environment is being put in place to make it happen - especially in the light of sustained growth within pharmaceutical, medical device, and clinical research. Important international players are already in operation locally as the country has established the appropriate legal and regulatory frameworks based on international norms, for the development of a strong biomedical research sector.
More info >>

 
Industry Events

Multimodal 2019

18-20 June 2019, NEC, Birmingham, UK

Now in its twelfth year, Multimodal is the UK and Ireland’s premier freight transport, logistics and supply chain management event.  Shippers and cargo owners attend to improve their businesses; by finding ways of moving their products more efficiently and by meeting new suppliers. 
More info >>

 

 

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement